Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Restatement of Financial Statements (Tables)

v3.10.0.1
Note 2 - Restatement of Financial Statements (Tables)
9 Months Ended
May 31, 2018
Accounting Changes and Error Corrections [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
The effects of the restatement on the Company’s consolidated balance sheet as of May 31, 2018 are as follows:

   

May 31, 2018

 
   

As Previously

   

Restatement

                 
   

Reported

   

Adjustment

   

Note

   

As Restated

 

Current assets - discontinued operations

  $ 3,897,293     $ (3,887,878 )     (1 )   $ 9,415  

Total current assets

  $ 4,210,563     $ (3,887,878 )     (1 )   $ 322,685  

Total Assets

  $ 4,210,563     $ (3,887,878 )     (1 )   $ 322,685  

Accounts payable and accrued liabilities

  $ 182,726     $ (117,534 )     (2 )   $ 65,192  

Derivative liability

  $ 880,192     $ 1,280,613       (3 )   $ 2,160,805  

Current liabilities - discontinued operations

  $ 5,594,700     $ 11,641,297       (4 )   $ 17,235,997  

Total current liabilities

  $ 6,909,785     $ 12,804,376       (5 )   $ 19,714,161  

Additional paid-in capital

  $ 6,444,585     $ (3,094,777 )     (6 )   $ 3,349,808  

Accumulated deficit

  $ (9,224,295 )   $ (13,597,477 )     (7 )   $ (22,821,772 )

Total stockholders' equity (deficit)

  $ (2,699,222 )   $ (16,692,254 )     (8 )   $ (19,391,476 )

Total liabilities and stockholders' equity (deficit)

  $ 4,210,563     $ (3,887,878 )     (9 )   $ 322,685  
   

Three Months Ended May 31, 2018

 
   

As Previously

   

Restatement

                 
   

Reported

   

Adjustment

           

As Restated

 
                                 

Interest expense

  $ (797,258

)

  $ 430,467       (10

)

  $ (366,791

)

Gain (loss) on restructuring of debt

  $ 10,226     $ 1,162,767       (11

)

  $ 1,172,993  

Gain (loss) on conversion of debt

  $ -     $ (139,325

)

    (12

)

  $ (139,325

)

Change in fair value of derivative liability

  $ (456,043

)

  $ (492,089

)

    (13

)

  $ (948,132

)

Total other income (expense), net

  $ (1,243,075

)

  $ (961,820

)

    (14

)

  $ (281,255

)

Net loss from continuing operations

  $ (1,482,586

)

  $ (961,820

)

    (15

)

  $ (520,764

)

Net income (loss) from discontinued operations

  $ (3,571,043

)

  $ (13,928,166

)

    (13

)

  $ (17,499,209

)

Consolidated Net loss

  $ (5,053,629

)

  $ (12,966,344

)

    (14

)

  $ (18,019,973

)

Net loss per share - continuing operations: basic and diluted

  $ (0.02

)

  $ (0.01

)

          $ (0.01

)

Net loss per share - discontinued operations: basic and diluted

  $ (0.04

)

  $ (0.17

)

          $ (0.22

)

Weighted average shares outstanding - basic and diluted

    79,683,842       -               79,683,842  
   

Nine Months Ended May 31, 2018

 
   

As Previously

   

Restatement

                 
   

Reported

   

Adjustment

   

Note

   

As Restated

 

Interest expense

  $ (1,702,312 )   $ 816,325    

(10a

)   $ (885,987 )

Gain (loss) on restructuring of debt

  $ 149,549     $ 877,711    

(11a

)   $ 1,027,260  

Gain (loss) on conversion of debt

  $ -     $ (474,649 )  

(12a

)   $ (474,649 )

Change in fair value of derivative liability

  $ (601,048 )   $ (888,700 )  

(13a

)   $ (1,489,748 )

Total other income (expense), net

  $ (2,153,811 )   $ (330,687 )  

(14a

)   $ (1,823,124 )

Net loss from continuing operations

  $ (2,544,780 )   $ (330,687 )  

(15a

)   $ (2,214,091 )

Net income (loss) from discontinued operations

  $ (3,571,043 )   $ (13,928,166 )     (13 )   $ (17,499,209 )

Consolidated Net loss

  $ (6,115,823 )   $ (13,597,477 )     (14 )   $ (19,713,300 )

Net loss per share - continuing operations: basic and diluted

  $ (0.03 )   $ (0.01 )           $ (0.03 )

Net loss per share - discontinued operations: basic and diluted

  $ (0.05 )   $ (0.18 )           $ (0.22 )

Weighted average shares outstanding - basic and diluted

    79,039,656       -               79,039,656  
   

Nine Months Ended May 31, 2018

 
   

As Previously

   

Restatement

                 
   

Reported

   

Adjustment

   

Note

   

As Restated

 
                                 

Net loss - continuing operations

  $ (2,544,780 )   $ 330,689       (15a )   $ (2,214,091 )

Derivative expense

  $ 1,056,966     $ 880,462       (18 )   $ 1,937,428  

Amortization of discount on convertible debt

  $ 1,033,549     $ (682,689 )     (19 )   $ 350,860  
Gain on note exchange   $ (149,549 )   $ (877,711 )     (20 )   $ (1,027,260 )
Loss on conversion of debt   $ -     $ 474,649       (21 )   $ 474,649  

Accounts payable and accrued liabilities

  $ 226,426     $ (494,182 )     (22 )   $ (267,756 )

Net cash used in operating activities - continuing operations

  $ (336,429 )   $ (368,782 )     (23 )   $ (705,211 )

Net cash used in operating activities - discontinued operations

  $ (367,327 )   $ 368,782       (23 )   $ 1,455  

Net increase in cash and cash equivalents - continuing operations

  $ 665,071     $ (368,782 )     (23 )   $ 296,289  

Net increase in cash and cash equivalents - discontinued operations

  $ (367,327 )   $ 368,782       (23 )   $ 1,455  

(1) $3,887,878: Write-off of the balance of the note receivable related to discontinued operations recorded during the period ended May 31, 2018 in the financial statements as originally filed, not recorded during the period ended May 31, 2018 as amended.

(2) ($117,534): Accrued interest on the loan payable related to discontinued operations charged to continuing operations in the financial statements as originally filed, charged to discontinued operations in the financial statements as amended.

(3) $1,280,613:  (i) $570,953: A derivative liability associated with a convertible note payable was charged to additional paid-in capital in the financial statements as originally filed, and charged to derivative liability in the financial statements as amended; (ii) $177,499: A derivative liability associated with the issuance of 500,000 warrants was not recorded in the financial statements as originally filed, and charged to derivative liability in the financial statements as amended; (iii) $532,161: mark to market of the derivative liability associated with 2,054,405 warrants not recorded in the financial statements as originally filed, charged to derivative liability in the financial statements as amended.

(4) $11,641,297:  (i) $7,988,090: Fair value of derivative liabilities in connection with 25,000,000 warrants were charged to additional paid-in capital in the financial statements as originally filed, charged to derivative liability in the financial statements as amended; (ii) $3,535,673: Revaluation of the derivative liability associated with the 25,000,000 warrants not recorded in the financial statements as originally filed, charged to derivative liability in the financial statements as amended; (iii)   $117,534: Accrued interest on the loan payable related to discontinued operations charged to continuing operations in the financial statements as originally filed, charged to discontinued operations as amended.

(5) $12,804,376: Net of (2), (3), and (4) above.

(6) $3,094,777: (i) $570,953: Fair value of the derivative liability associated with a convertible note payable was charged to additional paid-in capital in the financial statements as originally filed, and charged to derivative liability in the financial statements as amended; (ii) $7,988,090:  Fair value of a derivative liability in connection with 25,000,000 warrants in the amount of was charged to additional paid-in capital in the financial statements as originally filed, and charged to derivative liability in the financial statements as amended; (iii) $6,387,081: Fair value of 15,000,000 warrants cancelled in August, 2018, charged to additional paid-in capital in the financial statements as originally filed; not recorded in the financial statements as amended; (iv) net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $922,815.

(7) $13,597,477:  (i) $4,490,270 write-off of note receivable associated with discontinued operations in the amended financial statement, not in the financial statements as filed;  (ii) $3,535,673 revaluation of derivative liability related to  25,000,000 warrants as of May 31, 2018 in the amended financial statements, not in the financial statements as originally filed; (iii) $177,499 derivative expense – excess value of the derivative liability associated with 500,000  warrants in the amended financial statements, not in the financial statements as originally filed; (iv) $532,161 mark to market 2,054,405 warrants in the amended financial statements, not in the financial statements as originally filed; (v) $602,392: revaluation of Bitcoin at August 21, 2018 made in original financial statements, not in amended financial statements;  (vi) $6,387,081: gain on cancellation of 15,000,000 warrants recorded in the financial statements as  originally filed, not in the amended financial statements; (vii) net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $922,815.

(8) $16,692,254:  Net of (6) and (7) above.

(9) $3,887,878: Net of (5) and (8) above.

(10) $430,467:  (i) $117,534 interest on note payable charged to continuing operations in the financial statements as originally filed, moved to discontinued operations in the amended financial statements; (ii) $177,499: derivative in excess of principal amount of note associated with 500,000 warrants in amended financial statements, not recorded in financial statements as originally filed; (iii) net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $490,432.

(10a) $816,325:  (i) $117,534 interest on note payable charged to continuing operations in the financial statements as originally filed, moved to discontinued operations in the amended financial statements; (ii) $177,499: derivative in excess of principal amount of note associated with 500,000 warrants in amended financial statements, not recorded in financial statements as originally filed; (iii) net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $876,290.

(11) $1,162,767:  net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $1,162,767.

(11a) $877,711:  net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $877,711.

(12) $139,325:  net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $139,325.

(12a) $474,649:  net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $474,649.

(13) $492,089:  (i) $119,964 revaluation of derivative liability associated with 500,000 warrants in the amended financial statement, not in the financial statements as originally filed; (ii) $412,197 revaluation of derivative liability associated with 1,554,405 warrants in the amended financial statement, not in the financial statements as originally filed; (iii) net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $40,072.

(13a) $888,700:  (i) $119,964 revaluation of derivative liability associated with 500,000 warrants in the amended financial statement, not in the financial statements as originally filed; (ii) $412,197 revaluation of derivative liability associated with 1,554,405 warrants in the amended financial statement, not in the financial statements as originally filed; (iii) net effect of changes in connection with accounting for conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes: $356,539.

(14): $961,820:  Net of (10), (11), (12), and (13) above.

(14a): $330,687:  Net of (10a), (11a), (12a), and (13a) above.

(15) $961,820: Same as (14) above.

(15a): $330,687:  Same as (15a) above.

(16) $13,928,166:  (i) $4,490,270 Write off of note receivable in amended financial statements, not in financial statements as originally filed; (ii) $3,535,673 Revaluation of derivative liability associated with 25,000,000 warrants at May 31, 2018 in amended financial statements, not in financial statements as originally filed; (iii) $602,392 Revaluation of Bitcoin at August 21, 2018 in financial statements as originally filed, not in amended financial statements;  (iv) $6,387,081 gain on cancellation of 15,000,000 warrants in financial statements as originally filed, not in amended financial statements; (v) $117,534 interest on note payable in discontinued operations in financial statements as amended, in continuing operations in financial statements as originally filed.

(17) $12,966,344: Total of (15) and (16) above.

(17a) $13,957,477:  Net of (15a) and (16) above.

(18) $880,462: (i) $111,281 revaluation of non-warrant derivative liabilities at 11.30.17; (ii) $259,491: revaluation of non-warrant derivative liabilities at 02.28.18; (iii) $119,964:  $119,964 revaluation of derivative liability associated with 500,000 warrants in the amended financial statement, not in the financial statements as originally filed; (iv) $412,197: revaluation of derivative liability associated with 1,554,405 warrants in the amended financial statement, not in the financial statements as originally filed; derivative in excess of principal amount of note associated with 500,000 warrants in amended financial statements, not recorded in financial statements as originally filed; (v) $22,592:  net change attributable to accounting change for gain or loss due to conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes.

(19) $682,689: Net change attributable to accounting change for gain or loss due to conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes.

(20)  $877,711: Net change attributable to accounting change for gain or loss due to conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes.

(21): $474,649:  Net change attributable to accounting change for gain or loss due to conversion of convertible notes payable and accrued interest to equity, and restructure of certain convertible notes. 

(22) $494,181: Amount transferred to discontinued operations in the financial statements as amended.

(23) $368,782:  Sum of (15a), (18), (19), (20), (21), and (22) above.